Company Valuation: CS Diagnostics Corp.

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025
Market Cap 1 0.3951 150.6 76.47
Change - 38,005.96% -49.21%
Enterprise Value (EV) 1 0.3747 150.6 76.47
Change - 40,076.48% -49.21%
P/E -2,525x 232,000x 1,077x
PBR 0.11x 0.32x 0.15x
PEG - -2,263x 0x
Capitalization / Revenue 3.13x 1,357x 375x
EV / Revenue 2.97x 1,357x 375x
EV / EBITDA - - -
EV / EBIT -17x 197,840x 1,074x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -0.000198 0.000005 0.000284
Distribution rate - - -
Net sales 1 0.126 0.1109 0.204
EBITDA - - -
EBIT 1 -0.022 0.000761 0.0712
Net income 1 -0.022 0.000761 0.0712
Net Debt 1 -0.0204 -0.000501 -0.006813
Reference price 2 0.500000 1.160000 0.305900
Nbr of stocks (in thousands) 790 129,790 249,992
Announcement Date 7/29/25 7/29/25 4/15/26
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 2.12M
27.63x3.84x14.83x2.64% 169B
18.25x3.37x12.04x3.26% 110B
21.42x4.21x14.72x1.31% 106B
25.26x2.48x10.04x2.86% 73.87B
16.92x0.2x12.42x0.77% 58.98B
29.48x7.29x18.84x1.36% 51.28B
34.07x3.32x11.38x2.22% 48.16B
35.11x8.73x24.55x-.--% 40.84B
34.3x6.01x18.87x-.--% 32.21B
Average 26.94x 4.38x 15.30x 1.6% 69.02B
Weighted average by Cap. 25.35x 3.98x 14.47x 1.99%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. CSDX Stock
  4. Valuation CS Diagnostics Corp.